Unknown NA INTERVENTIONAL 2-arm NCT05364710

Clinical Proof-of-concept Study on Rapid Immune Modulating Effects

Clinical Poof-of-concept Study on Rapid Immune Modulating Effects

Sponsor: Natural Immune Systems Inc

Interventions Transfer factor from colostrum ultrafiltrate

Updated 4 times since 2022 Last updated: May 11, 2022 Started: May 7, 2022 Primary completion: Dec 31, 2022 Completion: Jun 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05364710, this NA trial focuses on Immune Surveillance and remains ongoing. Sponsored by Natural Immune Systems Inc, it has been updated 4 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jun 2024 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jun 2022 — Jun 2024 [monthly]

Recruiting NA

First recorded

May 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Natural Immune Systems Inc

Data source: Natural Immune Systems Inc

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Klamath Falls, United States